Cronos Group (NASDAQ: CRON) and one of the biggest U.S. integrated cannabis companies, PharmaCann Inc., announced that they’d signed an agreement whereby a Cronos Group subsidiary is set to buy an option to acquire an ownership stake of roughly 10.5% in PharmaCann on a wholly-diluted basis. There are several factors […]
